Skip to main content
. 2021 Feb 2;9(1):30. doi: 10.3390/pharmacy9010030

Table 2.

Distribution of Studies for each type of THN program identified (n = 18).

Theme Number of Intervention Studies (%)
Laws
Mandatory naloxone co-prescription with opioids 1 (5.6%) [27]
Standing order 2 (11.1%) [21,24]
Prescriptive authority 4 (22.2%) [19,21,24,31]
OTC status of naloxone 1 (5.6%) [30]
Education of pharmacy team prior to implementation 10 (55.5%) [18,22,23,24,29,31,32,33,34,35]
Interventions
PMS used to help flag patients eligible for naloxone 3 (16.6%) [28,34,35]
Checklists (patient eligibility, patient counselling) 4 (22.2%) [22,25,29,34]
Pocketcard 1 (5.6%) [23]
Patient brochure 4 (22.2%) [20,22,34,35]
Screening 4 (22.2%) [26,32,33,34]
Opt-out 1 (5.6%) [25]